| ID | JOS-jjphcs.28.571 |
| タイトル：カナ | イヤクヒン シハンゴ ニ ツイカ サレル ジュウダイ ナ フクサヨウ ノ ゲンジョウ |
| 別タイトル | Current Situation of the Additional Severe Adverse Effects of Marketed Medicine |
| 著者：名前 | 小林, 大介/ 久津間, 信明/ 中山, 惠/ 鵜近, 篤史/ 鈴木, 暢之/ 佐次田, 優子/ 遠藤, 敏成/ 上田, 秀雄/ 沼尻, 幸彦/ 駒田, 富佐夫/ 齋藤, 侑也/ 森本, 雍憲 |
| 著者：別形式 | Kobayashi, Daisuke / Kutsuma, Nobuaki / Nakayama, Megumi / Ukon, Atsushi / Suzuki, Nobuyuki / Sashida, Yuko / Endo, Toshinari / Ueda, Hideo / Numajiri, Sachihiko / Komada, Fusao / Saitoh, Yukiya / Morimoto, Yasunori |
| 著者：カナ | コバヤシ, ダイスケ/ クツマ, ノブアキ/ ナカヤマ, メグミ/ ウコン, アツシ/ スズキ, ノブユキ/ サシダ, ユウコ/ エンドウ, トシナリ/ ウエダ, ヒデオ/ ヌマジリ, サチヒコ/ コマダ, フサオ/ サイトウ, ユキヤ/ モリモト, ヤスノリ |
| 著者：所属 | 城西大学薬学部病院薬剤学講座 / 株式会社あさひ調剤 / 株式会社あさひ調剤 / 株式会社あさひ調剤 / 株式会社あさひ調剤 / 城西大学薬学部病院薬剤学講座 / 城西大学薬学部病院薬剤学講座 / 城西大学薬学部病院薬剤学講座 / 城西大学薬学部病院薬剤学講座 / 城西大学薬学部医薬品情報学講座 / 城西大学薬学部医薬品情報学講座 / 城西大学薬学部病院薬剤学講座 |
| 著者：所属(別形式） | Josai University, Faculty of Pharmaceutical Sciences, Department of Hospital Pharmacy / Asahi-chozai Co., Ltd. / Asahi-chozai Co., Ltd. / Asahi-chozai Co., Ltd. / Asahi-chozai Co., Ltd. / Josai University, Faculty of Pharmaceutical Sciences, Department of Hospital Pharmacy / Josai University, Faculty of Pharmaceutical Sciences, Department of Hospital Pharmacy / Josai University, Faculty of Pharmaceutical Sciences, Department of Hospital Pharmacy / Josai University, Faculty of Pharmaceutical Sciences, Department of Hospital Pharmacy / Josai University, Faculty of Pharmaceutical Sciences, Department of Drug Informatics / Josai University, Faculty of Pharmaceutical Sciences, Department of Drug Informatics / Josai University, Faculty of Pharmaceutical Sciences, Department of Hospital Pharmacy |
| 著者版フラグ | publisher |
| 出版地 | 東京 |
| 出版者 | 日本医療薬学会 |
| 出版者：カナ | ニホンイリョウヤクガクカイ |
| 出版者：別名 | Japanese Society of Pharmaceutical health Care and Sciences |
| NCID | AA11527197 |
| 冊子ISSN | 1346342X |
| 電子ISSN | 18821499 |
| 掲載誌名 | |
| 掲載誌名：翻訳 | Japanese Journal of Pharmaceutical Health Care and Sciences |
| 巻 | 28 |
| 号 | 6 |
| 刊行年月 | 2002 |
| 開始ページ | 571 |
| 終了ページ | 575 |
| コンテンツ作成日 | 2002-08-10 |
| コンテンツ登録日 | 2014-02-20 |
| 識別番号：DOI | info:doi/10.5649/jjphcs.28.571 |
| 識別番号：DOI（リンク） | |
| 識別番号：その他 | JOI:JST.Journalarchive/jjphcs2001/28.571 |
| 抄録 | When a novel additional adverse effect is reported for a marketed medicine, the medical information leaflet has to be revised to inform physicians and pharmacists of this. Pharmacists are responsible for informing patients of early warning symptoms to avoid the subsequent appearance of severe adverse effects. However, at present, patients may suffer from severe adverse events because such symptoms may remain unrecognized until the medicine is on the market. As a result, investigations to predict and prevent novel additional adverse effects of medicines are required. In this study, we investigated a novel additional adverse effect classified as a pharmacological effect based on the drug safety update (DSU). As a result, skin disorders including toxic epidermal necrolysis and Stevens Johnson syndrome, and pseudomembranous colitis have become evident as additional adverse effects of antibiotics, with a high incidence. In addition, neuroleptic malignant syndrome and aplastic anemia have also been reported as adverse effects of central nervous system agents. Therefore, it is important to provide patients with information about the early warning symptoms related to such adverse effects, even though such adverse effects are not contained in the patient information leaflet. |
| キーワード | |
| 言語 | jpn |
| 資源タイプ | text |
| ジャンル | |
| フォーマット | application/pdf |
| 権利 | Copyright ? 一般社団法人 日本医療薬学会 |
| このアイテムを表示する：本文(pdf) |  ( 765.5KB) ダウンロード回数： 回 |
| このアイテムを表示する：URI | |
